Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Assets (2016 - 2025)

Nephros has reported Assets over the past 16 years, most recently at $13.6 million for Q4 2025.

  • Quarterly results put Assets at $13.6 million for Q4 2025, up 21.69% from a year ago — trailing twelve months through Dec 2025 was $13.6 million (up 21.69% YoY), and the annual figure for FY2025 was $13.6 million, up 21.69%.
  • Assets for Q4 2025 was $13.6 million at Nephros, up from $13.2 million in the prior quarter.
  • Over the last five years, Assets for NEPH hit a ceiling of $18.0 million in Q2 2021 and a floor of $10.4 million in Q2 2023.
  • Median Assets over the past 5 years was $11.8 million (2023), compared with a mean of $13.2 million.
  • Biggest five-year swings in Assets: tumbled 37.68% in 2022 and later increased 27.55% in 2025.
  • Nephros' Assets stood at $17.6 million in 2021, then crashed by 37.68% to $11.0 million in 2022, then grew by 7.84% to $11.9 million in 2023, then decreased by 5.49% to $11.2 million in 2024, then rose by 21.69% to $13.6 million in 2025.
  • The last three reported values for Assets were $13.6 million (Q4 2025), $13.2 million (Q3 2025), and $12.2 million (Q2 2025) per Business Quant data.